Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis

被引:18
作者
Yang, Yichun [1 ]
Liu, Chengkai [1 ]
Yan, Jin [1 ]
Liu, Kebing [1 ]
机构
[1] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Ultrasound, 16 Airport Rd, Guangzhou 510000, Peoples R China
关键词
Perfluorobutane; Contrast-enhanced ultrasound; Hepatocellular carcinoma; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL-DIAGNOSIS; IMAGING MODALITIES; CIRRHOSIS PATIENTS; ULTRASOUND; LESIONS; SURVEILLANCE; AGENT; SONOGRAPHY; ACID;
D O I
10.1007/s00261-021-03141-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives Perfluorobutane ultrasound contrast agent as a new type of contrast agent has a good performance in the diagnosis of hepatocellular carcinoma (HCC). This study aim to evaluate the accuracy and reliability of Perfluorobutane contrast-enhanced ultrasonography (P-CEUS) in the diagnosis of HCC with a systematic review and meta-analysis. Methods Web of Science, EMBASE, Cochrane, Clinical Key, Wan Fang, CBM and CNKI databases were systematically searched and checked for studies using P-CEUS in HCC, from 2007 to 2020. Data necessary to construct 2 x 2 contingency tables were extracted from included studies. The QUADAS tool was utilized to assess the methodologic quality of the studies. Meta-analysis included data pooling, subgroup analyses, meta-regression and investigation of publication bias was comprehensively performed. Results Nine studies were included in this meta-analysis and the overall diagnostic accuracy in characterization of HCC was as follows: pooled sensitivity, 0.90 (95% confidence interval: 0.82-0.95); pooled specificity, 0.97 (0.93-0.98); pooled positive likelihood ratio, 27.2 (14.1 to - 52.3); and pooled negative likelihood ratio, 0.10 (0.06-0.18). The area under the comprehensive receiving operation characteristic curve was 0.98 (0.97-0.99). Conclusion The sensitivity and specificity of P-CEUS are more valuable than other imaging techniques (such as computer tomography or magnetic resonance imaging). However, due to the large differences in the data samples collected in this study, statistical heterogeneity results. P-CEUS can significantly improve the diagnostic efficiency of previous contrast-enhanced ultrasound for HCC. PROSPERO registration number: PROSPERO (CRD42020200040).
引用
收藏
页码:4619 / 4628
页数:10
相关论文
共 44 条
[1]   Usefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tomography [J].
Alaboudy, Alshimaa ;
Inoue, Tatsuo ;
Hatanaka, Kinuyo ;
Chung, Hobyung ;
Hyodo, Tomoko ;
Kumano, Seishi ;
Murakami, Takamichi ;
Moustafa, Ehab Fawzy Abdou ;
Kudo, Masatoshi .
ONCOLOGY, 2011, 81 :66-72
[2]   Evaluation of the use of intraoperative real-time virtual sonography with sonazoid enhancement for detecting small liver metastatic lesions after chemotherapy in hepatic resection [J].
Araki, Kenichiro ;
Harimoto, Norifumi ;
Muranushi, Ryo ;
Hoshino, Kouki ;
Hagiwara, Kei ;
Yamanaka, Takahiro ;
Ishii, Norihiro ;
Tsukagoshi, Mariko ;
Igarashi, Takamichi ;
Watanabe, Akira ;
Kubo, Norio ;
Shirabe, Ken .
JOURNAL OF MEDICAL INVESTIGATION, 2019, 66 (3-4) :319-323
[3]   Usefulness of Contrast-Enhanced Intraoperative Ultrasound Using Sonazoid in Patients With Hepatocellular Carcinoma [J].
Arita, Junichi ;
Takahashi, Michiro ;
Hata, Shojiro ;
Shindoh, Junichi ;
Beck, Yoshifumi ;
Sugawara, Yasuhiko ;
Hasegawa, Kiyoshi ;
Kokudo, Norihiro .
ANNALS OF SURGERY, 2011, 254 (06) :992-999
[4]   Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid [J].
Barr, Richard G. ;
Huang, Pintong ;
Luo, Yan ;
Xie, Xiaoyan ;
Zheng, Rongqin ;
Yan, Kun ;
Jing, Xiang ;
Luo, Yukun ;
Xu, Huixiong ;
Fei, Xiang ;
Lee, Jeong Min .
ABDOMINAL RADIOLOGY, 2020, 45 (11) :3779-3788
[5]   Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma [J].
Bolondi, Luigi ;
Cillo, Umberto ;
Colombo, Massimo ;
Craxi, Antonio ;
Farinati, Fabio ;
Giannini, Edoardo G. ;
Golfieri, Rita ;
Levrero, Massimo ;
Pinna, Antonio Daniele ;
Piscaglia, Fabio ;
Raimondo, Giovanni ;
Trevisani, Franco ;
Bruno, Raffaele ;
Caraceni, Paolo ;
Ciancio, Alessia ;
Coco, Barbara ;
Fraquelli, Mirella ;
Rendina, Maria ;
Squadrito, Giovanni ;
Toniutto, Pierluigi .
DIGESTIVE AND LIVER DISEASE, 2013, 45 (09) :712-723
[6]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[7]   Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma [J].
Goto, Eriko ;
Masuzaki, Ryota ;
Tateishi, Ryosuke ;
Kondo, Yuji ;
Imamura, Jun ;
Goto, Tadashi ;
Ikeda, Hitoshi ;
Akahane, Masaaki ;
Shiina, Shuichiro ;
Omata, Masao ;
Yoshida, Haruhiko ;
Koike, Kazuhiko .
JOURNAL OF GASTROENTEROLOGY, 2012, 47 (04) :477-485
[8]   A unification of models for meta-analysis of diagnostic accuracy studies [J].
Harbord, Roger M. ;
Deeks, Jonathan J. ;
Egger, Matthias ;
Whiting, Penny ;
Sterne, Jonathan A. C. .
BIOSTATISTICS, 2007, 8 (02) :239-251
[9]   Differential diagnosis of hepatic tumors: Value of contrast-enhanced harmonic Sonography using the newly developed contrast agent, Sonazoid [J].
Hatanaka, Kinuyo ;
Kudo, Masatoshi ;
Minami, Yasunori ;
Ueda, Taisuke ;
Tatsumi, Chie ;
Kitai, Satoshi ;
Takahashi, Shunsuke ;
Inoue, Tatsuo ;
Hagiwara, Satoru ;
Chung, Hobyung ;
Ueshima, Kazuomi ;
Maekawa, Kiyoshi .
INTERVIROLOGY, 2008, 51 :61-69
[10]   The Gross Classification of Hepatocellular Carcinoma: Usefulness of Contrast-enhanced US [J].
Hatanaka, Kinuyo ;
Minami, Yasunori ;
Kudo, Masatoshi ;
Inoue, Tatsuo ;
Chung, Hobyung ;
Haji, Seiji .
JOURNAL OF CLINICAL ULTRASOUND, 2014, 42 (01) :1-8